Fangzhou Inc. (06086.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.8x

Market Cap

HKD 1.09B

MomentumView details →

1D Return

+7.95%

YTD Return

−63.78%

RSI (14)

68.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.8x

Market Cap

HKD 1.09B

RSI (14)

68.7

MomentumView details →

1D Return

+7.95%

YTD Return

−63.78%

ProfitabilityView details →

Gross Margin

17.61%

Net Margin

−13.50%

EBITDA Margin

−11.59%

ROE (TTM)

−548.17%

ROA (TTM)

−103.54%

Asset Turnover

7.89x

GrowthView details →

Revenue YoY

+24.94%

EPS YoY

−23.53%

FCF YoY

+275.92%

Revenue CAGR 3Y

+16.95%

EPS CAGR 3Y

+101.01%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

HKD 0.01

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

−7.19%

Capital & dividendView details →

Debt/Equity

0.23x

Current Ratio

1.20x

Quick Ratio

0.92x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

6.24B

Net Income (TTM)

−843.05M

Op. CF (TTM)

94.90M

Next earningsMar 19, 2027 →

Latest newsMore news →

Fangzhou Inc. reported its interim results for the six months ended June 30, 2026, with revenue of RMB1.82 billion, up 22.2% year-over-year, and adjusted net profit of RMB18.7 million, up 6.4%.8d ago

Similar companies

Beijing Biostar Pharms Co Ltd02563.HK Modern Chinese Medicine Group Co., Ltd.01643.HK TYK Medicines, Inc02410.HK 天目药业600671.SH Organon & Co.OGN Tong Ren Tang Technologies Co. Ltd.01666.HK Find similar companies →

Latest newsMore news →

Fangzhou Inc. reported its interim results for the six months ended June 30, 2026, with revenue of RMB1.82 billion, up 22.2% year-over-year, and adjusted net profit of RMB18.7 million, up 6.4%.8d ago